rxstat › Drug prices › Cysteamine

Cysteamine (Cystadrops) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Cysteamine 25 mg capsule (delayed-release) costs about $5.95 per capsule on public drug plan price lists across 4 provinces, before the pharmacy's dispensing fee.

Cysteamine has no current shortage reported in Canada. No active reports are on file.

Price by province

Strength and formABSKNBNS
25 mg Capsule (Delayed-Release)per capsule$5.95$5.95$5.95$5.95
75 mg Capsule (Delayed-Release)per capsule$17.86$17.86$17.86$17.86
0.37% w/w Solutionper mL$397.20–$397.20$397.20
Plan coverageCoveredSpecial approvalSpecial approvalSpecial approval

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it. Provinces bill some products (injectables especially) per mL and others per pen or vial, so compare prices with the same unit.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 3 products
  • Procysbi 25 mg Capsule (Delayed-Release) · AMG
    DIN 02464705 · $5.95/capsule · Covered
  • Procysbi 75 mg Capsule (Delayed-Release) · AMG
    DIN 02464713 · $17.86/capsule · Covered
  • Cystadrops 0.37 %/w/w Solution · RRD
    DIN 02485605 · $397.20/mL · Covered
Saskatchewan: 2 products
  • Procysbi 25 mg Capsule (Delayed-Release) · AMG
    DIN 02464705 · $5.95/capsule · Special approval
  • Procysbi 75 mg Capsule (Delayed-Release) · AMG
    DIN 02464713 · $17.86/capsule · Special approval
New Brunswick: 3 products
  • Procysbi 25 mg Capsule (Delayed-Release) · AGA
    DIN 02464705 · $5.95/capsule · Special approval
  • Procysbi 75 mg Capsule (Delayed-Release) · AGA
    DIN 02464713 · $17.86/capsule · Special approval
  • Cystadrops 0.37 %/w/w Solution · RRD
    DIN 02485605 · $397.20/mL · Special approval
Nova Scotia: 3 products
  • Procysbi 25 mg Capsule (Delayed-Release) · AGA
    DIN 02464705 · $5.95/capsule · Special approval
  • Procysbi 75 mg Capsule (Delayed-Release) · AGA
    DIN 02464713 · $17.86/capsule · Special approval
  • Cystadrops 0.37 %/w/w Solution · RRD
    DIN 02485605 · $397.20/mL · Special approval

Price sources: Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 1
Reports on file
1

Reports by product

Resolved
CYSTADROPS
0.37% · SOLUTION · RECORDATI RARE DISEASES CANADA INC
DIN 02485605 · ended Apr 14, 2020 · Disruption of the manufacture of the drug.

What's happening

There are no active shortage reports for Cysteamine.

Recent changes

Common questions

How much does Cysteamine cost in Canada?

Cysteamine 25 mg capsule (delayed-release) costs about $5.95 per capsule on public drug plan price lists across 4 provinces, before the pharmacy's dispensing fee.

Is Cysteamine covered by provincial drug plans?

On the public plans' own lists: Alberta: covered; Saskatchewan: special approval; New Brunswick: special approval; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Cysteamine be back in stock in Canada?

Cysteamine has no active shortage; supply is normal per Health Canada reports.

Why is Cysteamine in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.